UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota Journal article
Dong, Lingling, Du, Hongling, Zhang, Minyue, Xu, Haiting, Pu, Xiulan, Chen, Qiyan, Luo, Ruifeng, Hu, Yichen, Wang, Yitao, Tu, He, Zhang, Jinming, Gao, Fei. Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota[J]. Phytotherapy Research, 2022, 36(5), 2081 - 2094.
Authors:  Dong, Lingling;  Du, Hongling;  Zhang, Minyue;  Xu, Haiting;  Pu, Xiulan; et al.
Favorite | TC[WOS]:101 TC[Scopus]:110  IF:6.1/7.0 | Submit date:2022/05/17
Antiinflammation  Gut Microbiota  Network Pharmacology  Pi3k/akt/mtor Signaling Pathway  Rhein  Ulcerative Colitis  
Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis Journal article
Lin, Meisi, Dong, Lingling, Chen, Qiyan, Xu, Haiting, Han, Xiaoqin, Luo, Ruifeng, Pu, Xiulan, Qi, Shanshan, Nie, Wenbiao, Ma, Meilin, Wang, Yitao, Gao, Fei, Zhang, Jinming. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis[J]. Frontiers in Bioengineering and Biotechnology, 2021, 9, 702173.
Authors:  Lin, Meisi;  Dong, Lingling;  Chen, Qiyan;  Xu, Haiting;  Han, Xiaoqin; et al.
Favorite | TC[WOS]:26 TC[Scopus]:26  IF:4.3/5.1 | Submit date:2021/12/08
Lentinan  Budesonide  Macrophage-target  Oral Nanoparticles  Ulcerative Colitis